Daniel Corum

1.1k total citations
18 papers, 779 citations indexed

About

Daniel Corum is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Daniel Corum has authored 18 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Hematology and 3 papers in Genetics. Recurrent topics in Daniel Corum's work include Acute Myeloid Leukemia Research (6 papers), Mitochondrial Function and Pathology (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Daniel Corum is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Mitochondrial Function and Pathology (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Daniel Corum collaborates with scholars based in United States, Saudi Arabia and Spain. Daniel Corum's co-authors include Rick G. Schnellmann, Ryan Whitaker, Craig C. Beeson, David J. Dix, Daniel M. Rotroff, Andrew L. Beam, Nicole Kleinstreuer, Beth Padnos, Nisha S. Sipes and David M. Reif and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Daniel Corum

16 papers receiving 769 citations

Peers

Daniel Corum
Agnieszka Wnuk Poland
Kun Yi United States
Joanna Rzemieniec Poland
Christine Curran United States
Ikram Elayan United States
Lyubomir G. Nashev Switzerland
Jinko Sawashita Japan
Mikko Unkila Finland
Teresa Gasull Spain
Ian Edwards United Kingdom
Agnieszka Wnuk Poland
Daniel Corum
Citations per year, relative to Daniel Corum Daniel Corum (= 1×) peers Agnieszka Wnuk

Countries citing papers authored by Daniel Corum

Since Specialization
Citations

This map shows the geographic impact of Daniel Corum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Corum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Corum more than expected).

Fields of papers citing papers by Daniel Corum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Corum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Corum. The network helps show where Daniel Corum may publish in the future.

Co-authorship network of co-authors of Daniel Corum

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Corum. A scholar is included among the top collaborators of Daniel Corum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Corum. Daniel Corum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Corum, Daniel, et al.. (2025). Akt3 links mitochondrial function to the regulation of Aurora B and mitotic fidelity. PLoS ONE. 20(3). e0315751–e0315751.
3.
Wang, Eunice S., Pau Montesinos, Ghayas C. Issa, et al.. (2025). Ziftomenib in relapsed/refractory (R/R) NPM1 -mutant acute myeloid leukemia (AML): Phase 1b/2 clinical activity and safety results from the pivotal KOMET-001 study.. Journal of Clinical Oncology. 43(16_suppl). 6506–6506. 3 indexed citations
4.
Zeidan, Amer M., Eunice S. Wang, Ghayas C. Issa, et al.. (2024). Ziftomenib Combined with Intensive Induction (7+3) in Newly Diagnosed NPM1-m or KMT2A-r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET-007. Blood. 144(Supplement 1). 214–214. 14 indexed citations
5.
6.
7.
Zeidan, Amer M., Amir T. Fathi, Ghayas C. Issa, et al.. (2023). Phase 1 study of ziftomenib (KO-539) in combination with venetoclax or venetoclax/azacitidine or standard induction cytarabine/daunorubicin (7+3) chemotherapy for the treatment of patients with acute myeloid leukemia.. Journal of Clinical Oncology. 41(16_suppl). TPS7079–TPS7079. 5 indexed citations
8.
Zeidan, Amer M., Amir T. Fathi, Ghayas C. Issa, et al.. (2023). PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA. HemaSphere. 7(S3). e56956b1–e56956b1. 2 indexed citations
9.
Gromeier, Matthias, et al.. (2021). Safety and efficacy of murine PVSRIPO plus anti-PD-1 immune checkpoint inhibitor (ICI) in a melanoma tumor model.. Journal of Clinical Oncology. 39(15_suppl). 2560–2560. 1 indexed citations
10.
Corum, Daniel, James A. Heslop, Gyda Beeson, et al.. (2020). PDE5 inhibition rescues mitochondrial dysfunction and angiogenic responses induced by Akt3 inhibition by promotion of PRC expression. Journal of Biological Chemistry. 295(52). 18091–18104. 10 indexed citations
11.
Scholpa, Natalie E., Wenxue Wang, Daniel Corum, et al.. (2018). Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved β 2 -Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury. Journal of Neurotrauma. 36(6). 962–972. 47 indexed citations
12.
Scholpa, Natalie E., et al.. (2017). 5‐HT1F receptor‐mediated mitochondrial biogenesis for the treatment of Parkinson's disease. British Journal of Pharmacology. 175(2). 348–358. 37 indexed citations
13.
Rotroff, Daniel M., Daniel Corum, Alison A. Motsinger‐Reif, et al.. (2016). Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants. Translational Psychiatry. 6(9). e894–e894. 78 indexed citations
14.
Rotroff, Daniel M., Noffisat O. Oki, Xiaomin Liang, et al.. (2016). Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans. Frontiers in Pharmacology. 7. 135–135. 27 indexed citations
15.
Whitaker, Ryan, Daniel Corum, Craig C. Beeson, & Rick G. Schnellmann. (2015). Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases. The Annual Review of Pharmacology and Toxicology. 56(1). 229–249. 162 indexed citations
16.
Corum, Daniel, Philip N. Tsichlis, & Robin C. Muise‐Helmericks. (2013). AKT3 controls mitochondrial biogenesis and autophagy via regulation of the major nuclear export protein CRM‐1. The FASEB Journal. 28(1). 395–407. 33 indexed citations
17.
Padilla, Stephanie, Daniel Corum, Beth Padnos, et al.. (2011). Zebrafish developmental screening of the ToxCast™ Phase I chemical library. Reproductive Toxicology. 33(2). 174–187. 253 indexed citations
18.
Martin, Matthew T., Daniel Corum, Richard Judson, et al.. (2009). Profiling the Reproductive Toxicity of Chemicals from Multigeneration Studies in the Toxicity Reference Database. Toxicological Sciences. 110(1). 181–190. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agnieszka Wnuk Breakdown of academic impact, for papers by Kun Yi Breakdown of academic impact, for papers by Joanna Rzemieniec Breakdown of academic impact, for papers by Christine Curran Breakdown of academic impact, for papers by Ikram Elayan Breakdown of academic impact, for papers by Lyubomir G. Nashev Breakdown of academic impact, for papers by Jinko Sawashita Breakdown of academic impact, for papers by Mikko Unkila Breakdown of academic impact, for papers by Teresa Gasull Breakdown of academic impact, for papers by Ian Edwards
Rankless by CCL
2026